Related Experiment Videos
Canalith repositioning for benign paroxysmal positional vertigo: a randomized, controlled trial
S Asawavichianginda1, P Isipradit, K Snidvongs
1Department of Otolaryngology, Chulalongkorn University, Bangkok, Thailand.
Ear, Nose, & Throat Journal
|September 30, 2000
Summary
The canalith repositioning maneuver offered short-term symptom relief for benign paroxysmal positional vertigo (BPPV). However, its effectiveness diminished over time compared to no treatment.
Area of Science:
- Neurology
- Otolaryngology
- Vestibular Disorders
Background:
- Benign paroxysmal positional vertigo (BPPV) is a common cause of vertigo.
- Canalith repositioning maneuvers are frequently used to treat BPPV.
Purpose of the Study:
- To evaluate the 6-month efficacy of the canalith repositioning maneuver compared to no treatment for BPPV.
Main Methods:
- A randomized, controlled trial was conducted.
- Patients with BPPV were randomized to either the maneuver or a control group.
- Outcomes were assessed via subjective symptom reports and objective Hallpike testing.
Main Results:
- The treated group showed significantly better outcomes than the control group within the first month.
- This significant difference in efficacy was not maintained at 3 and 6 months.
Conclusions:
- The canalith repositioning maneuver provides initial symptom improvement for BPPV.
- Long-term efficacy of the maneuver alone is not sustained at 3 and 6 months post-treatment.